Wrenda Teeple on pharmacogenomics implementation, study design, and the PGx Long Game

Published: Nov. 15, 2021, 7:54 p.m.

b'Wrenda Teeple, the Chief Clinical Officer and Director of Regulatory Affairs at Arbit Consulting, joins us today to provide her expertise on PGx implementation, study designs, and the tension between the evidence we have and the evidence that we need.\\n\\nShow Notes:\\n1:30 \\u2013 Introductions\\n5:40 \\u2013Wrenda\\u2019s Passion for PGx\\n6:45 \\u2013 STRIPE and Playing the PGx Long game\\n11:05 \\u2013 Studying PGx\\n13:25 \\u2013 What is the validity and implications of the data?\\n18:47 \\u2013 The tension improving quality of evidence and implementing PGx today.\\n24:00 \\u2013 Under Construction\\n26:20 \\u2013 Wrenda\\u2019s key takeaways\\n29:00 \\u2013 Resources to investigate'